Shelton Capital Management Bio Rad Laboratories, Inc. Transaction History

Shelton Capital Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$454.43 - $535.6 $572,127 - $674,320	-1,259 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$334.87 - $493.06 $19,422 - $28,597	-58 Reduced 4.4%	1,259 $568,000
Q1 2020 May 13, 2020	SELL	$320.01 - $409.07 $15,680 - $20,044	-49 Reduced 3.59%	1,317 $462,000
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $266,557 - $290,396	929 Added 212.59%	1,366 $427,000
Q1 2019 May 10, 2019	SELL	$224.3 - $317.41 $222,505 - $314,870	-992 Reduced 69.42%	437 $1.43 Million
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $28,076 - $32,893	-120 Reduced 7.75%	1,429 $357,000
Q3 2017 Nov 28, 2017	BUY	$212.27 - $242.28 $328,806 - $375,291	1,549 New	1,549 $344,000
Q3 2017 Nov 14, 2017	SELL	$212.27 - $242.28 $328,806 - $375,291	-1,549 Closed	0 $0
Q4 2016 Nov 29, 2017	SELL	N/A	-564 Reduced 26.69%	1,549 $282,000
Q3 2016 Dec 06, 2017	BUY	N/A	564 Added 36.41%	2,113 $346,000
Q3 2016 Dec 04, 2017	BUY	N/A	1,549	1,549 $282,000

453

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.68B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.